A year in review: IGTP’s most notable achievements in 2024
We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.
At the IGTP TODAY
News
Can Ruti Campus remains a globally significant scientific centre due to its medical and research staff
Once again, the names of around thirty renowned professionals - from the Hospital and the Germans Trias i Pujol Research Institute (IGTP), the Fight Infections Foundation, IrsiCaixa, the Josep Carreras Leukaemia Research Institute (IJC), and the Institut Català d'Oncologia (ICO) - appear on a global list of scientists who have achieved the highest impact through their publications and citations.
IGTP secures over €2 million in state funding for research projects focused on technological innovation and scientific advancement
IGTP has received grants for six research projects in two calls from the Spanish Research Agency, under the State Plan for Scientific and Technical Research and Innovation 2021-2023.
Mitral valve repair via catheter offers better outcomes than pharmacological treatment in patients with heart failure
A new study, published in New England Journal of Medicine, has demonstrated the benefits of placing a clip on the valve instead of the usual medical treatment. The study includes the participation of Professor Antoni Bayés-Genís, principal investigator of the ICREC group and Director of the Heart Institute at Germans Trias Hospital.
_1725960548.jpg)
- Research
A new drug shows potential benefits in the recovery of patients after a heart attack
Researchers from the Cardiac Regeneration and Heart Failure Research Group (ICREC) at the Germans Trias i Pujol Research Institute (IGTP) and the Heart Institute of the Germans Trias Hospital (iCor) have found beneficial effects of the novel drug Sacubitril/Valsartan in the management of myocardial infarction (MI).
_1715606541.jpg)
First cardiac bioimplants for the treatment of patients with myocardial infarction using umbilical cord stem cells
The results of a pioneering study by IGTP and BST support the safety of the bioimplants called PeriCord, made from stem cells of the umbilical cord and pericardium from a tissue donor, which aid in the regeneration and revascularisation of the affected area.
Celebrating International Women's Day: the voice of our professionals
To commemorate International Women's Day, we asked four questions to researchers from various profiles at IGTP and professionals from different research support areas. The aim is to understand the difficulties they have faced as women in their professional field and to gain insight into their perspectives on the future.
Medical and research staff at the Can Ruti Campus, once again among the world’s most prominent in the scientific field
The Can Ruti Campus and the healthcare and research teams of the different institutions that comprise it continue to prove, once again this year, to be a relevant node on a global scale in terms of scientific production and progress.
Artificial intelligence and advanced therapies are the focus of the ICS Conference, hosted by IGTP
The 14th Research Conference of the ICS focused on the transformative potential of research in the health system and awarded prizes to eight researchers. Antoni Bayés and Alejandro Bustamante, who work at the Hospital and researchers at IGTP, were awarded a prize for the best hospital scientific career and ICS young researcher, respectively.
IGTP, IQS (URL) and BST are working together to develop bypass surgery using donor veins
One of the most commonly practised cardiovascular health interventions, the coronary bypass, could undergo a revolutionary innovation with the joint research carried out by the Blood and Tissue Bank (BST), the Germans Trias i Pujol Research Institute (IGTP) and the Vascular Engineering and Applied Biomedicine Group (GEAB) of the IQS (URL). The three centres are working to develop a vascular graft from donor veins that can be used for bypass surgery to restore blood flow.
